{"pub": "morningstar", "url": "https://morningstar.com/news/dow-jones/201910228304/biogen-up-over-31-on-pace-for-record-percent-increase-data-talk", "downloaded_at": "2019-10-22 15:34:11.199034+00:00", "title": "Biogen Up Over 31%, On Pace for Record Percent Increase \u2014 Data Talk", "language": "en", "text": "Biogen Inc. (BIIB) is currently at $294.00, up $70.49 or 31.54%\n\n-- Would be highest close since March 20, 2019, when it closed at $320.59\n\n-- Would be largest percent increase on record (Based on available data back to Sept. 17, 1991)\n\n-- Earlier Tuesday, Biogen said it will seek regulatory approval early next year for an Alzheimer's disease drug some seven months after pulling the plug on late-stage studies of the drug\n\n-- The company posted third-quarter net income of $1.55 billion, or $8.39 a share, compared with $1.44 billion, or $7.15 a share, in the comparable quarter last year. Analysts polled by FactSet were expecting $7.82 a share\n\n-- Currently up two consecutive days; up 33.6% over this period\n\n-- Best two day stretch since the two days ending June 2, 2000, when it rose 35.46%\n\n-- Up 26.28% month-to-date\n\n-- Down 2.3% year-to-date\n\n-- Down 7.01% from 52 weeks ago (Oct. 23, 2018), when it closed at $316.15\n\n-- Up 42.28% at today's intraday high; largest intraday percent increase on record (Based on available data back to Sept. 17, 1991)\n\n-- Best performer in the S&P 500 today\n\n-- Fifth most active stock in the S&P 500 today\n\n-- Best performer in the Nasdaq 100 today\n\n-- Second most active stock in the Nasdaq 100 today\n\nAll data as of 10:42:04 AM\n\nSource: Dow Jones Market Data, FactSet\n\n(END) Dow Jones Newswires\n\nOctober 22, 2019 11:06 ET (15:06 GMT)\n\nCopyright (c) 2019 Dow Jones & Company, Inc.", "description": "", "authors": [], "top_image": "https://morningstar.com/assets/img/30241a1.png", "published_at": "2019-10-22"}